Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Effects of mindfulness-based interventions on negative emotions in patients with hypertension: a systematic review and meta-analysis.

Created on 14 Nov 2026

Authors

Jiawei Lin, Changqun Lian, Guiting Zhou, Jiantao Liu, Yanlang Hua, Peijian Liu

Published in

Frontiers in cardiovascular medicine. Volume 13. Pages 1941304. Epub Oct 30, 2026.

Abstract

Psychological distress is common in hypertension and may impair disease management. Mindfulness-based interventions have been proposed to improve emotional and health-related outcomes, but evidence in this population remains limited.
This systematic review and meta-analysis followed PRISMA guidelines. PubMed, Embase, Web of Science, the Cochrane Library, and CNKI were searched up to December 31, 2025, for randomized controlled trials of mindfulness interventions in adults with hypertension. Continuous outcomes were pooled as standardized mean differences (SMDs) with 95% confidence intervals (CIs) using fixed- or random-effects models. Risk of bias was assessed with the Cochrane tool, and the certainty of evidence was evaluated using the GRADE approach.
Nine trials with 780 participants were included. Mindfulness interventions significantly reduced depressive symptoms (SMD = -1.19, 95% CI: -1.74 to -0.64) and anxiety (SMD = -1.43, 95% CI: -2.48 to -0.39). Perceived stress was also reduced (SMD = -0.53, 95% CI: -0.82 to -0.24). Systolic (SMD = -2.10, 95% CI: -3.81 to -0.38) and diastolic blood pressure (SMD = -1.55, 95% CI: -2.69 to -0.42) were modestly reduced. Risk of bias was generally low to moderate. According to GRADE, the certainty of evidence was moderate for depression, systolic and diastolic blood pressure, and low for anxiety, perceived stress, and quality of life.
Mindfulness-based interventions improve psychological outcomes in hypertension and may modestly lower blood pressure, supporting their use as a complementary strategy in hypertension management.
https://www.crd.york.ac.uk/PROSPERO/, PROSPERO CRD420261328666.

PMID:
43031733
Bibliographic data and abstract were imported from PubMed on 14 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement